Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity
about
Cloned Defective Interfering Influenza RNA and a Possible Pan-Specific Treatment of Respiratory Virus DiseasesDefective viral genomes: critical danger signals of viral infectionsEvidence for a Novel Mechanism of Influenza Virus-Induced Type I Interferon Expression by a Defective RNA-Encoded ProteinInfluenza virus activation of the interferon systemlncRHOXF1, a Long Noncoding RNA from the X Chromosome That Suppresses Viral Response Genes during Development of the Early Human PlacentaPersistent RNA virus infections: do PAMPS drive chronic disease?Collective Infectious Units in VirusesParallel ClickSeq and Nanopore sequencing elucidates the rapid evolution of defective-interfering RNAs in Flock House virus.Biological activities of 'noninfectious' influenza A virus particlesFlaviviral RNAs: weapons and targets in the war between virus and host.Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans.IFN-β-inducing, unusual viral RNA species produced by paramyxovirus infection accumulated into distinct cytoplasmic structures in an RNA-type-dependent mannerIn Vivo RNAi Screening Identifies MDA5 as a Significant Contributor to the Cellular Defense against Influenza A VirusActivity of Uncleaved Caspase-8 Controls Anti-bacterial Immune Defense and TLR-Induced Cytokine Production Independent of Cell DeathIdentification of a Natural Viral RNA Motif That Optimizes Sensing of Viral RNA by RIG-I.Late regulation of immune genes and microRNAs in circulating leukocytes in a pig model of influenza A (H1N2) infection.Propagation and Characterization of Influenza Virus Stocks That Lack High Levels of Defective Viral Genomes and Hemagglutinin MutationsPlasmacytoid Dendritic Cells Require Direct Infection To Sustain the Pulmonary Influenza A Virus-Specific CD8 T Cell Response.Low-Fidelity Polymerases of Alphaviruses Recombine at Higher Rates To Overproduce Defective Interfering Particles.Spatial-Temporal Patterns of Viral Amplification and Interference Initiated by a Single Infected Cell.Deficiency of melanoma differentiation-associated protein 5 results in exacerbated chronic postviral lung inflammation.Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity.Defective interfering viruses and their impact on vaccines and viral vectors.Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells In Vitro: Contribution of the Cleavage Site of Fusion Protein and Second Sialic Acid Binding Site of Hemagglutinin-Neuraminidase.Single-cell studies of IFN-β promoter activation by wild-type and NS1-defective influenza A viruses.Attenuation of RNA viruses by redirecting their evolution in sequence space.Human IFIT1 Inhibits mRNA Translation of Rubulaviruses but Not Other Members of the Paramyxoviridae Family.Activation of the interferon induction cascade by influenza a viruses requires viral RNA synthesis and nuclear export.An unbiased genetic screen reveals the polygenic nature of the influenza virus anti-interferon response.Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses.Population Diversity and Collective Interactions during Influenza Virus Infection.Revisiting the concept of a cytopathic viral infection.Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA.The innate immune response to RSV: Advances in our understanding of critical viral and host factors.Reduced accumulation of defective viral genomes contributes to severe outcome in influenza virus infected patients.Replication defective viral genomes exploit a cellular pro-survival mechanism to establish paramyxovirus persistence.A single amino acid substitution within the Paramyxovirus Sendai virus nucleoprotein is a critical determinant for production of IFN-beta-inducing copyback-type defective interfering genomes.Active Ebola Virus Replication and Heterogeneous Evolutionary Rates in EVD Survivors.Extreme heterogeneity of influenza virus infection in single cells.Low-fidelity Venezuelan equine encephalitis virus polymerase mutants to improve live-attenuated vaccine safety and efficacy.
P2860
Q26799938-9D5B2F9F-06AB-4A26-A1AE-605EEC1CD368Q26824882-A9DB4569-3700-44EC-A8BE-AA4DF252741CQ27319771-CC594538-5D16-4C99-A188-AE6FA1421186Q28088483-2D1AFC12-13D5-43BA-88BD-CABE26F338D5Q28601277-62904F0C-F0EB-4D27-A0F6-9680F69A2A98Q28804036-B51C8674-84E3-4FDE-BE87-70B2D4DF8FB0Q29464175-6CC706F8-4DD7-4B3F-BCD6-DF6A2E45C393Q33699574-55996730-F0D7-4708-9FE2-B58483BAA28FQ33943672-8127F03D-7A67-4246-A005-74D8DCB3007EQ34432758-3B56532C-3531-4CA7-912B-ED19C9678A0FQ35763742-271211D2-74EB-41A0-A4B8-EAEE131A065FQ35913195-E9451912-EB9A-41A6-97BC-090FDFF80D05Q36100793-DDC20264-5A78-48D9-A976-0435963C9A0CQ36162984-736FE387-159F-4B19-88D5-5877B7325AA6Q36177534-E300B03B-3E82-4C81-96A9-C2705349CAA8Q36595617-45287779-493B-49B2-8224-50F09AB87412Q36717688-566FDED2-8BEB-47DC-AB24-4CDF5294E5E4Q36736704-028C9BFB-FD7C-4C9A-8A3B-8CC701BCDD49Q36736866-FBF4FD8A-6ED3-4C94-BC4E-D3C0A4E68FD7Q37174414-166C54F9-9333-4CB1-95A0-02704A2A90FAQ37688505-972BD0B4-75C6-4D28-8D80-C0D37AE93B71Q37707676-00CD3450-AC49-4E0F-859F-1E0EF78511E5Q38366471-993D3CFD-0784-44D9-AFE0-CEE417627AAAQ38700909-4F1117EB-08FB-4656-978C-711DBCF765C7Q38725926-DA85356D-65AB-45CD-9BCA-9F5E9A473182Q38743913-69A00F4C-90D7-4D41-B751-29C82AE97F79Q38752527-C6D9ABCA-6CDA-47D9-9EAB-7AE27E5DA86AQ38858552-6060286B-E427-4D1D-A5C4-A42CB0B6B68DQ38860549-CC0D0B7C-7412-439C-AEC3-B6F13896DCA8Q39432584-184DF0A3-99AC-45D2-A35E-A79EA8088A6BQ40064406-09023BE0-449B-4823-B289-9A6B044C6A23Q40114886-C3C08A4C-20FC-44D5-8347-648BB4D6FCBEQ40153229-2A8E3071-DA6D-49DE-B30E-B2E262F988E0Q40522232-38FB32CB-085F-402C-AAA0-86519440BAB3Q41918223-E2C6E3EC-13CA-4080-9E6A-5AD8C51E0729Q41922546-820D7F81-53A1-44DA-B9E7-5D1CE79EE932Q46241883-F9BCEBC5-2DA3-4A3B-B22F-7DA6F5942DA8Q47547522-AE485F18-4689-418C-99D9-E15140531DD8Q49933555-C296FAED-FA51-44B8-8973-6CF7BAB98498Q54246382-4E58BE84-7ED5-4F33-85F8-7BE403701669
P2860
Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Defective viral genomes arisin ...... ing of lung antiviral immunity
@ast
Defective viral genomes arisin ...... ing of lung antiviral immunity
@en
type
label
Defective viral genomes arisin ...... ing of lung antiviral immunity
@ast
Defective viral genomes arisin ...... ing of lung antiviral immunity
@en
prefLabel
Defective viral genomes arisin ...... ing of lung antiviral immunity
@ast
Defective viral genomes arisin ...... ing of lung antiviral immunity
@en
P2093
P2860
P1433
P1476
Defective viral genomes arisin ...... ing of lung antiviral immunity
@en
P2093
Emily Dunay
Karla Tapia
Megan Wise
Michael Adu
Won-Keun Kim
Xiomara Mercado-López
P2860
P304
P356
10.1371/JOURNAL.PPAT.1003703
P577
2013-10-31T00:00:00Z